Clinical Factors Affecting Bevacizumab Efficacy With and Without Conventional Chemotherapy in Metastatic Colon Cancer

Conclusions: Better OS among mCRC patients with resectable primary and metastatic tumors was seen. This is the first study to demonstrate slightly better outcome in males and negative influence of diabetes on outcome in mCRC treated with BZ.
Source: American Journal of Therapeutics - Category: Drugs & Pharmacology Tags: Therapeutic Opinion Source Type: research